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Abstract
The novel pandemic A (H1N1) virus was first identified in Mexico in April 2009 and quickly spread worldwide. Like all
influenzas, the H1N1 strain-specific properties of replication, virulence, and pathogenicity are a result of the particular
genomic sequence and concerted expression of multiple genes. Thus, specific mutations may support increased virulence
and may be useful as biomarkers of potential threat to human health. We performed comparative genomic analysis of ten
strains of the 2009 pandemic A (H1N1) influenza viruses to determine whether genotypes associated with clinical
phenotypes, which ranged from mild to severe illness and up to lethal. Virus replication capacity was tested for each strain
in vitro using cultured epithelial cells, while virulence and pathogenicity were investigated in vivo using the BALB/c mouse
model. The results indicated that A/Sichuan/1/2009 strain had significantly higher replication ability and virulence than the
other strains, and five unique non-synonymous mutations were identified in important gene-encoding sequences. These
mutations led to amino acid substitutions in HA (L32I), PA (A343T), PB1 (K353R and T566A), and PB2 (T471M), and may be
critical molecular determinants for replication, virulence, and pathogenicity. Our results suggested that the replication
capacity in vitro and virulence in vivo of the 2009 pandemic A (H1N1) viruses were not associated with the clinical
phenotypes. This study offers new insights into the transmission and evolution of the 2009 pandemic A (H1N1) virus.
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Introduction
The first influenza pandemic of the 21
st century was declared
with the emergence of a novel influenza A (H1N1) strain in
Mexico and the United States in April 2009 [1]. Genetic analysis
of this novel virus revealed that it is composed of six gene segments
which were derived from the triple-reassortant swine lineage and
two others from the Eurasian avian-like swine lineage [1]. Thus
far, the A (H1N1) influenza has caused a relatively mild pandemic,
with a clinical spectrum ranging from slight upper respiratory tract
irritation to severe pneumonia leading to acute respiratory distress
syndrome [2]. Sporadic cases have occurred in which infection led
to death, but those individuals most often had impaired immune
status prior to influenza exposure. It is interesting to note that the
Spanish influenza pandemic of 1918 and the Hong Kong
influenza pandemic of 1968 were both characterized by a first
wave of cases which elicited relatively mild illness, followed by a
second wave of cases of fulminant disease [3]. The viral molecular
mechanisms underlying this robust increase in disease severity
have remained elusive; however, it has been hypothesized that
pandemic viruses rely on advantageous genetic mutations to adapt
to the human host upon zoonotic transmission. As a result, the
newly evolved virus will generate a wave of more virulent cases
than the first wave. Such genetic adaptation could also occur via
gene reassortment events between co-circulating influenza A
viruses in the human population.
The virulence, pathogenicity, and host range of influenza
viruses have been intensely studied and many diverse factors have
been implicated in each. In particular, virus-specific determinants
encoded by the viral genome have been defined as principal
components of virus survival and pathogenesis; these include the
external surface glycoproteins hemagglutinin (HA) and neuramin-
idase (NA), which interact with host membrane-bound sialic acids
[4,5,6,7]. In addition, influenza encodes three polymerase
proteins, which have been characterized as important determi-
nants of strains H5N1 and H7N7and necessary for transmission of
the 1918 H1N1 virus [5,6,8,9]. The two nonstructural proteins
PB1-F2 [10,11] and NS1 [12] have also been implicated in the
virulence capacities of H5N1 and 1918 H1N1 viruses. Intriguing-
ly, genome sequence analysis of the 2009 pandemic A (H1N1)
viruses revealed a striking absence of markers associated with high
pathogenicity in avian and mammalian species, including the
multibasic HA cleavage site [13] and the lysine at position 627 in
the PB2 protein [14,15,16,17].
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variations on infection characteristics, we investigated the genomic
polymorphisms that occurred among ten strains of the 2009
pandemic A (H1N1) viruses. Virus replication was analyzed in an
in vitro cell culture system, and virulence and pathogenicity were
tested in vivo in a mouse model. The findings from our study
provide insights into the functional contributions of viral genomic
polymorphisms in virus replication, virulence, and pathogenicity,
and implicate molecular evolution as a significant driving force
behind the 2009 pandemic A (H1N1) influenza virus.
Materials and Methods
Viruses
The main background information for all ten virus strains is listed
in Table 1. The naming conventions follow the pattern: Type/
Geographic Location/Strain Number/Year of Isolation. The A/
California/04/2009 and A/California/07/2009 are considered the
prototypic strains of the 2009 pandemic A (H1N1) influenzaviruses.
The A/Sichuan/1/2009 strain was isolated from the first reported
case of 2009 pandemic A (H1N1) influenza virus infection in China;
the patient was a Chinese student who had returned from the
United States in May 2009. The patient reported that no illness
symptoms were experienced during the flight from St. Louis to
Beijing, but fever developed on the following day during the flight
from Beijing to Sichuan. The source of infection remains unknown
[18]. A/Sichuan-Wenjiang/SWL456/2009 was collected from a
deceased patient, and A/Guangdong/SWL28/2009 was collected
from a patient with severe clinical symptoms. A/California/04/
2009, A/California/07/2009, A/Sichuan/1/2009, A/Shandong/
1/2009, A/Beijing/3/2009, A/Fujian/1/2009, A/Shanghai/1/
2009, and A/Jiangsu/1/2009 viruses were all collected from
patients with mild symptoms. The passage history of these viruses
is listed in Table 1. All viruses were propagated in Madin–Darby
canine kidney(MDCK) cells. The 50%tissue culture infectiousdose
(TCID50) was determined by using serial titration of viruses in
MDCK cells, and the titers were calculated according to the Reed-
Muench method [19].
Cell infection
MDCK cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) (Invitrogen) supplemented with 10% fetal
bovine serum. Viruses (10
2 TCID50) were added to respective
cell monolayers in 35-mm dishes (Corning). After 60 min
adsorption at 37uC, cells were washed and fed with minimum
essential medium containing tosylsulfonyl phenylalanyl chloro-
methyl ketone (TPCK)-treated trypsin (0.5 mg/ml) (Sigma) and
antibiotics (Sigma). This time point was designated as 0 hour post-
infection (h.p.i.). Viral supernatants (100 ml) were harvested at 12,
24, 36, 48, 56, 72, 96 h.p.i. and separated from cell debris by
centrifugation at 30006g for 10 min.
Mice challenge
Female 5-week-old specific pathogen-free BALB/c mice used in
this study were obtained from the Institute of Laboratory Animal
Sciences, Beijing, China. Mice were anesthetized and inoculated
intranasally with virus (n=23 per group; 50 mlo f1 0
6 TCID50). In
each group 10 mice were chosen at random for daily monitoring
for signs of disease and mortality, up to 14 days post inoculation
(d.p.i.). Ten of the remaining mice in each group were euthanized
at 5 d.p.i. to obtain lung tissue biopsies for use in subsequent
quantification of viral nucleotide material and pathological
investigations. The final 3 mice were sacrificed at 5 d.p.i. and
lungs were collected for viral titer detection. All procedures were
approved by the Institute of Animal Use and Care Committee of
the Institute of Laboratory Animal Science, Peking Union Medical
College (approval number ILAS-PC-2010-002).
Plaque assay
The infectivity of viruses released from infected MDCK cells
into supernatants and in the homogenized lung tissues of
challenged mice were determined by plaque assay and expressed
as log10 plaque-forming units (PFU) per milliliter [20]. Briefly,
confluent MDCK cells were incubated at 37uC for 1 hour with 10-
fold serial dilutions of virus. The cells were then washed and
overlaid with minimum essential medium containing 0.3% bovine
serum albumin (BSA), 0.9% Bacto agar, and 1 mg/ml TPCK-
treated trypsin and antibiotics. Plaques were visualized by neutral
red staining and counted after 48 hours of incubation at 37uC.
Real-time PCR
Total RNA was isolated from homogenized lung tissues by using
the RNeasy Mini Kit (Qiagen), according to the manufacturer’s
instructions. RNA was resuspended in 30 ml nuclease-free water
Table 1. The main background information of the ten 2009 pandemic A (H1N1) influenza viruses investigated in this study.
Strain
Patient clinical
symptom
Collection date
(YYYY/MM/DD) Collection location
Host
(Sex, age in years) Passage
#
A/California/04/2009 Mild 2009/04/01 California, USA Male, 10 E4
A/California/07/2009 Mild 2009/04/09 California, USA Male, 54 E4
A/Sichuan/1/2009 Mild 2009/05/09 Sichuan, China Male, 30 E3
A/Shandong/1/2009 Mild 2009/05/10 Shandong, China Male, 19 E4
A/Beijing/3/2009 Mild 2009/05/20 Beijing, China Male, 19 C2
A/Fujian/1/2009 Mild 2009/05/22 Fujian, China Female, 1 E2
A/Shanghai/1/2009 Mild 2009/05/23 Shanghai, China Male, 30 E2
A/Jiangsu/1/2009 Mild 2009/06/15 Jiangsu, China Male, 46 C1
A/Guangdong/SWL28/2009 Severe 2009/08/08 Guangdong, China Male, 17 C1
A/Sichuan-Wenjiang/SWL456/2009 Dead 2009/11/06 Sichuan, China Male, 53 C2
#: E, propagated in in the allantoic cavities of chicken embryonated eggs; C, propagated in MDCK cells.
doi:10.1371/journal.pone.0020698.t001
Polymorphism of H1N1 Affect Replication/Virulence
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20698and stored at 280uC. First-strand cDNA was synthesized from
RNA (8 ml) by random primers in a SuperScript II reverse
transcriptase (200 U) reaction mixture (20 ml) (Invitrogen). SYBR
Green real-time quantitative PCR was performed with a StepOne
PCR system (ABI) using cDNA (2 ml) and a reaction mixture
(20 ml) containing 26 SYBR Green PCR Master Mix (10 ml)
(ABI), 10 mM forward and reverse primers (1 ml each: SW-HA
F786, 59-AATAACATTAGAAGCAACTGG-39; SW-HA R920,
59-AGGCTGGTGTTTATRGCACC-39), and nuclease-free wa-
ter. The following thermal cycling conditions were used: 94uC for
3 min, followed by 35 cycles of 94uC for 30 s, 58uC for 30 s, and
72uC for 30 s.
Pathological analysis
Immediately following euthanasia, mouse lungs were removed,
inflated, and fixed with 10% neutral buffered formalin overnight
at 4uC. Subsequently, the formalin-preserved lung samples were
embedded in paraffin and sectioned. Serial 4-mm sections were
stained with Hematoxylin and Eosin (H&E) and examined for
pathological changes that corresponded to infection. Images were
obtained on an Olympus BX-50 light microscope at 406
magnification.
Receptor-binding assay
Synthetic SA-a-2,3-lactose(39SL-PAA)-Biotin, 39SL-DI-PAA-
Biotin, SA-a-2,6-N-acetyl lactosamine(69SLN-PAA)-Biotin,
69SLN-DI-PAA-Biotin were provided by The Scripps Research
Institute (La Jolla, CA, USA). The receptor binding procedure was
carried out as described elsewhere, with some modifications [21].
Briefly, 96-well flat–bottom polystyrene plates were coated with
serial dilutions of sialyglycopolymers, and 32 HAU of live virus
were added per well. Rabbit antisera against the A/California/
07/2009 strain were diluted in phosphate buffered saline
containing 1% bovine serum albumin and then added to each
well. Bound antibody was detected by sequential additions of
HRP-conjugated anti-rabbit IgG antibody and tetramethylbenzi-
dine substrate solution and reading the spectrophotometric
absorbance at 450 nm. Each sample was determined in triplicate.
DNA sequencing and analysis
All gene segments for each of the ten viruses were amplified by
high fidelity PCR (KOD-Plus DNA polymerase; Toyobo, Japan).
The PCR products were purified and sequenced (Invitrogen).
Sequences of each gene of A/Guangdong/SWL28/2009 and A/
Sichuan-Wenjiang/SWL456/2009 viruses were deposited in
GenBank. Sequences of all viruses were analyzed and aligned
using ClustalW software (version 1.83).
Statistical analysis
Statistical analysis of the viral load and titer were performed
using SPSS 11.5 software. The Duncan and least significant
differences methods were used for comparisons among multiple
groups by one-way ANOVA. The Kaplan-Meier method was used
to estimate the probability of survival of infected mice. A
probability value of 0.05 was considered as statistically significant.
Results
In vitro comparison of virus replication in cells
Analysis of virus replication kinetics in MDCK cells revealed
that all ten viruses reached their peak titers at 36 to 48 h.p.i, and
the titers of A/Sichuan/1/2009 were significantly higher (P,0.05)
than those obtained with other strains after 12 h.p.i (Fig. 1).
In vivo comparison of virulence in the mice model
To compare the virulence of the ten pandemic A (H1N1)
influenza viruses in vivo, we intranasally challenged BALB/c mice
with each virus and evaluated mortality, mean survival days, total
body weight loss, viral RNA loads and titers in lung tissues. The
percentages of mice that survived the infections are shown in
Figure 2A. Eighty percent of mice inoculated with the A/Sichuan/
1/2009 virus died by 14 d.p.i. Mice infected with the A/
California/04/2009 and A/California/07/2009 had survival
ratios of 60% and 70%, respectively. Furthermore, the A/
Fujian/1/2009, A/Shanghai/1/2009, and A/Guangdong/
SWL28/2009 viruses were associated with survival ratios ranging
from 50–70%. Challenge with A/Shandong/1/2009, A/Beijing/
3/2009, A/Jiangsu/1/2009, or A/Sichuan-Wenjiang/SWL456/
2009 was associated with 100% survival. The mean survival days
[22] of each mice group are shown in Figure 2B. The A/Sichuan/
1/2009 virus challenged mice survived only 6.8 days, and
represented the shortest survival time of all groups. Meanwhile,
challenge with A/Sichuan/1/2009 led to nearly 40% body weight
loss by 7–9 d.p.i, after which the mice began to steadily regain the
lost weight over the course of the remaining observation period.
The body weight losses of mice which were challenged with A/
California/04/2009, A/California/07/2009, A/Fujian/1/2009,
A/Shanghai/1/2009, or A/Guangdong/SWL28/2009 ranged
from 20% to 30%, whereas those inoculated with A/Beijing/3/
2009, A/Shandong/1/2009, A/Jiangsu/1/2009, or A/Sichuan-
Wenjiang/SWL456/2009 were less than 20% (Fig. 2C).
To further investigate the differences in pathogenicity of each
virus, we determined the degree of virus replication occurring in
lung tissues of challenged mice. The mean viral RNA loads (copy
numbers per mg 6 standard deviation (SD); Fig. 2D) and viral
titers (log10 PFU per mg; Fig. 2E) were determined at day 5 post-
infection, when virus shedding is known to reach its peak
according to our previous studies [23,24]. Mice inoculated with
the A/Sichuan/1/2009 virus presented with the highest RNA
copy numbers of virus in the lungs and significantly higher
(P,0.05) viral RNA load than the other nine viruses. Consistent
with the viral RNA load result, lung tissues of mice challenged
with A/Sichuan/1/2009 exhibited the highest viral titer.
In order to examine the differential pathological changes that
may take place in the lungs of mice challenged with the different
strains of virus, lung tissues were isolated day 5 post-infection. All
viruses were found to have replicated efficiently in the lung tissues.
In addition, all lung tissue samples exhibited characteristic
pathology of influenza infection, including inflammatory hyper-
aemia, hemorrhage, edema, and exudative pathological changes.
Mice lungs harboring A/Sichuan/1/2009 virus exhibited the most
robust pathophysiology, with lesions occurring in 100% of the lung
tissue sections examined. Mice inoculated with A/California/04/
2009, A/California/07/2009, A/Shanghai/1/2009, and A/Fu-
jian/1/2009 viruses exhibited pathological changes in .85% of
the lung tissue sections. Infection with A/Shandong/1/2009, A/
Beijing/3/2009, A/Jiangsu/1/2009, A/Guangdong/SWL28/
2009, and A/Sichuan-Wenjiang/SWL456/2009 viruses were
associated with lesion occurrence in 60–85% of lung tissues
(Fig. 3A&B).
Sequence alignment of A (H1N1) viral genomes
The full-length sequences of all ten viral genomes were obtained
by high fidelity PCR and sequenced as described in the Methods
section. The sequences of the HA, NA, M2&M1, NEP&NS1, NP,
PA, PB1, and PB2 genes in A/Guangdong/SWL28/2009 and A/
Sichuan-Wenjiang/SWL456/2009 viruses were deposited in
GenBank under accession numbers HM051340 to HM051347,
Polymorphism of H1N1 Affect Replication/Virulence
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phisms found in each of the ten viruses are listed in Table 2. In
particular, unique non-synonymous mutations were found in some
of the virulence genes of A/Sichuan/1/2009: a Leu-to-Ile
variation at position 32 in the HA coding sequence and another
four substitutions in the polymerases: Ala-to-Thr at position 343 in
PA, Lys-to-Arg at position 353 and Thr-to-Ala at position 566 in
PB1, and Thr-to-Met at position 471 in PB2.
Effect of HA Leu32Ile substitution on receptor binding
ability
Previous studies have suggested that HA mutations may act to
increase virus virulence by affecting the affinity of HA binding to
host sialyl receptors. We examined three representative strains (A/
California/04/2009, A/Sichuan/1/2009, A/Beijing/3/2009) and
measured their HA receptor binding abilities to synthetic sialic
substrates. No significant difference was observed in the affinities
of the three HAs for binding to human-type 69SLN or 69DI-SLN
and avian-type 39SL or 39DI-SL receptors (P.0.05) (Fig. 4). This
finding demonstrated that the HA Leu32Ile mutation in A/
Sichuan/1/2009 contributed minimally, or not at all, to the
uniquely high virulence phenotype.
Discussion
Influenza viruses cause epidemics and pandemics through
antigenic drift or antigenic shift [25]. The 2009 pandemic A
(H1N1) virus has generally been associated with mild disease and a
relatively low mortality rate; however, sporadic severe or fatal
cases have been reported. Certainly, discrepancies in individual
immunity may support such diverse virulence of the 2009
pandemic A (H1N1) viruses, but it is as likely that some yet
undefined viral molecular mechanisms are at play [3,26].
Mutations in specific regions of a given viral genome are known
to result in increased virulence, and may lead to a more severe
pandemic. In this study, we investigated the molecular basis of the
2009 pandemic A (H1N1) virus that mediates its uniquely robust
characteristics of replication, virulence, and pathogenicity.
We first examined the viral replication kinetics of all ten viruses
by using an in vitro infection model of MDCK cells. The A/
Sichuan/1/2009 strain had an obvious enhanced replication
ability, which led to increased peak titers of roughly 3–4 orders of
magnitude higher than the other viruses, with the exception of A/
California/04/2009 and A/California/07/2009 strains. These
two viruses exhibited 2–3 orders of magnitude lower viral titers, as
compared with A/Sichuan/1/2009 after 12 h.p.i. We also
performed in vivo analysis using the BALB/c mouse model.
Pronounced virulence and pathogenicity of the A/Sichuan/1/
2009 virus were both observed; mice infected with this virus had
the lowest survival ratio, shortest mean survival days, most
extensive body weight loss, highest virus RNA copy numbers
and titers in lung tissues, most severe pathological changes, and
largest lesion areas in lung tissues. Taken together, these in vitro
and in vivo results indicated that the A/Sichuan/1/2009 virus has
the strongest replication ability in MDCK cells and virulence in
the BALB/c mouse model.
Sequence alignment among the ten A (H1N1) viruses revealed
that the A/Sichuan/1/2009 virus genome harbors five unique
mutations: L32I in HA; A343T in PA; K353R and T566A in PB1;
and T471M in PB2. Receptor binding assay showed that despite
having a non-synonymous mutation in the HA gene, the A/
Sichuan/1/2009 virus did not have increased binding affinity for
synthetic sialyl receptors, including the human type 69SLN and the
avian type 39SL. Thus, it is unlikely that the HA Leu32Ile
mutation acts as a key molecular determinant for the increased
virulence of A/Sichuan/1/2009. While previous studies have
associated another mutation in the HA receptor binding domain,
Asp222Gly, with enhanced virulence [24,27,28,29,30,31], it
remains to be confirmed whether HA affinity for sialyl receptors
is directly responsible for the enhanced virulence of the 2009
pandemic A (H1N1) influenza viruses. However, Glinsky and
Melidou et al. presented findings to suggest that the HA
Gln293His amino acid change may be associated with increased
disease severity [32,33].
The polymerase genes of influenza viruses are considered to be
extremely important for virulence. Codon position 515 in the PA
Figure 1. Replication kinetics of the ten 2009 pandemic A (H1N1) influenza viruses in MDCK cells. Each data point represents the mean
viral yield (log10 PFU/ml) from three individually infected wells 6 SD. *P,0.05 compared to the values of other viruses (one-way ANOVA).
doi:10.1371/journal.pone.0020698.g001
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PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20698protein, for example, is significantly related to pathogenicity of an
H5N1 virus in ducks [34]. A reverse genetics study demonstrated
that mutations in the PB2 protein, Glu627Lys and Asp701Asn,
were responsible for virulence in mammalian species [8]. The
amino acid at position 701 in PB2 has been characterized as
crucial to replication and lethality of duck-originated H5N1
viruses in mice [35]. The same PB2 amino acid residue was shown
to contribute to increased lethality of an H7N1 avian influenza
virus in a mouse model [36]. However, Jagger et al. reported that
influenza viruses containing mutations at residues 627 and 701 in
the context of the pandemic A (H1N1) virus polymerase complex
have attenuated virulence both in cell culture and the mouse
Figure 3. Pathological analysis of the lung tissues of challenged BALB/c mice. Ten mice from each group were euthanized at 5 d.p.i. to
obtain lung tissue biopsies, and for each lung three 4-mm sections were stained with H&E for pathological investigations. (A) Representative sections
of H&E stained lung tissues from 10
6 TCID50 intranasally challenged mice. (B) Percentage of lesion area in lung tissues.
doi:10.1371/journal.pone.0020698.g003
Figure 2. Virulence comparison of the ten 2009 pandemic A (H1N1) influenza viruses in BALB/c mice. Mice were anesthetized and
inoculated intranasally with virus (n=23 per group; 50 mlo f1 0
6 TCID50). Ten randomly selected mice were monitored daily for signs of disease and
mortality, up to 14 d.p.i. for (A), (B), and (C) research, whereas ten of the remaining mice from each group were euthanized at 5 d.p.i. to obtain lung
tissue biopsies for use in (D). The final three mice were also sacrificed at 5 d.p.i. and their lungs were collected for (E) detection. (A) Survival
percentage of mice. (B) Mean survival days for each challenged group. (C) Body weight changes of infected mice. Mean body weight and SD were
calculated as percentage of body weight and compared to those at 0 d.p.i. (D) Viral RNA loads in lung tissues at 5 d.p.i. Data are presented as mean
viral loads per microgram 6 SD. (E) Viral titers in lung tissues at 5 d.p.i. Data are presented as mean log10 PFU/mg. * P,0.05 compared to the values
of other viruses (one-way ANOVA).
doi:10.1371/journal.pone.0020698.g002
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found to enhance polymerase activity and viral growth in human
cells [37]. PB2 residue 158 has been described as a pathogenic
determinant of the pandemic H1N1 and H5 influenza A viruses in
mice [38]. Moreover, PB1-F2, a short viral protein of approx-
imately 90 amino acids expressed from a +1 reading frame in the
PB1 gene segment, was also reported as another virulence
determinant; the serine at position 66 in PB1-F2 was associated
with increased disease pathology in a mouse model [11,39,40].
Interestingly, the 2009 pandemic A (H1N1) influenza viruses do
not encode a PB1-F2 protein, due to the presence of three stop
codons in the gene sequence. However, Wanitchang et al. and Hai
et al. reported that reinstatement of PB1-F2 elicited a minimal
effect on virulence of the pandemic A (H1N1) virus in various
mammalian models [41,42].
All the above data suggest that the polymerase complex
mediates virulence of influenza viruses. Indeed, the four residues
mutated within the polymerase complex of A/Sichuan/1/2009
virus may indicate key virulence determinants of the 2009
pandemic A (H1N1) viruses. However, it is still uncertain whether
the increased virulence is caused by any single substitution or some
combinations of the four. Further investigations using reverse
genetics are likely to provide insights into this question.
Epidemiologic analysis showed that the ten viruses examined in
this study could be divided into three groups based on time and
region of prevalence. Group I contained the A/California/04/
2009 and A/California/07/2009 viruses, which represented the
very first 2009 pandemic A (H1N1) influenza patients reported.
Group II contained the A/Sichuan/1/2009 strain, which was
isolated from the first reported case in China. As these Group II
strains were isolated during the earliest phase of the Chinese
pandemic, this group also represented the period of H1N1 global
dissemination [43]. Group III contained the other seven strains,
which were representative of domestic infections and were all
collected in China. The same HA sequence polymorphism found
in A/Sichuan/1/2009 existed in other 2009 pandemic A (H1N1)
strains which were collected across the globe from April to June of
2009. Most of these other strains represented the first waves of
H1N1 in their respective countries, including Canada, Mexico,
Nicaragua, France, Finland, and the United States. Interestingly,
PA mutation in A/Sichuan/1/2009 has never been reported
before. In contrast, sequence polymorphisms in PB1 and PB2 have
been identified in strains collected from the first waves in Canada,
Nicaragua, and some cities of the United States, but little
information is available about the virulence and pathogenicity of
those particular strains.
Belseretal.alsouseda mousemodeltoevaluatethe virulenceofa
collection of 2009 A (H1N1) viruses. Their studies ultimately
demonstrated that the viruses exhibited mild to moderate virulence
in mice. They also performed sequence analysis of their isolates, and
identified similar polymorphisms to those reported here; molecular
features which are frequently found among viruses of high
pathogenicity in mammalian models were not detected in either
their or our studies [44]. Although it was reported that
Figure 4. Direct binding assay with synthetic sialylglycopolymers. (A) Affinity to synthetic 39SL or 39DI-SL. (B) Affinity to synthetic 69SLN or
69DI-SLN.
doi:10.1371/journal.pone.0020698.g004
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pandemic A (H1N1) viruses, including those isolated from fatal
cases [44], however, it is likely that some, at least subtle, affects from
the cytokine storm exist to the virulence [45,46,47,48,49,50]. Since
none of the genetic changes identified in A/Sichuan/1/2009
involve critical domain/motifs in HA or in the polymerase complex
[8,51,52,53], further study addressing the potential for host-based
differences in immunologic response is warranted.
Our results also suggested that the virulence of the 2009
pandemic A (H1N1) viruses were not associated with the clinical
phenotypes of the corresponding patients; A/Sichuan-Wenjiang/
SWL456/2009 and A/Guangdong/SWL28/2009, viruses col-
lected from a deceased and severely ill patient respectively, showed
much lower replication ability, virulence, and pathogenicity than
A/Sichuan/1/2009, a virus from a patient with mild symptoms.
Previous investigations into a series of severe and fatal cases of the
pandemic H1N1 influenza revealed that pregnancy, obesity,
diabetes, and other co-morbid conditions were associated with
severe disease [54,55]. Therefore, it is reasonable to hypothesize
that the two patients with A/Sichuan-Wenjiang/SWL456/2009
or A/Guangdong/SWL28/2009 virus infection were suffering
from concomitant complicating diseases. Unfortunately, time and
anonymity concerns have made it impossible to now trace the
clinical features and anamnesis of these two patients. It is
interesting to note, here, that Belser et al. deduced the same
conclusion, citing that 2009 H1N1 viruses isolated from fatal cases
did not demonstrate enhanced virulence in a mouse model as
compared with isolates from mild human cases [44].
In summary, we found that the genomic polymorphisms that
characterize each of the 2009 pandemic A (H1N1) influenza
viruses contribute to virus replication ability, virulence, and
pathogenicity. Non-synonymous polymorphisms associated with
amino acid substitutions in PA (A343T), PB1 (K353R and
T566A), and PB2 (T471M) were identified as potential key
virulence determinants. Meanwhile, the replication ability in vitro
and virulence in vivo of the 2009 pandemic A (H1N1) viruses were
not associated with the clinical phenotypes exhibited by the
corresponding patients. These preliminary observations contribute
to our understanding of the genetic process of transmission and
evolution of the 2009 pandemic A (H1N1) influenza viruses.
Because of the functional importance of the polymerase complex
in replication, virulence, and pathogenicity, the mutations
described here deserve further investigation and may lead to
discoveries of new vaccines and therapeutic drugs against this
globally important virus.
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